Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Discacciati

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
European Urology Oncology|November 19, 2024
Repeat Prostate Cancer Screening using Blood-based Risk Prediction or Prostate-specific Antigen in the Era of Magnetic Resonance Imaging-guided Biopsies : A Secondary Analysis of the STHLM3-MRI Randomized Clinical TrialAndrea Discacciati, Ahmad Abbadi, Mark S Clements, et al.
Critical Care Medicine|November 16, 2013
B-type natriuretic peptide and risk of acute kidney injury in patients hospitalized with acute coronary syndromes*Marco Moltrasio, Angelo Cabiati, Valentina Milazzo, et al.
The New England Journal of Medicine|July 8, 2021
MRI-Targeted or Standard Biopsy in Prostate Cancer ScreeningMartin Eklund, Fredrik Jäderling, Andrea Discacciati, et al.
JAMA Network Open|February 7, 2024
Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging: A Secondary Analysis of the STHLM3-MRI Randomized Clinical TrialTobias Nordström, Magnus Annerstedt, Axel Glaessgen, et al.
Cardiovascular Research|November 20, 2016
Low TLR7 gene expression in atherosclerotic plaques is associated with major adverse cardio- and cerebrovascular eventsGlykeria Karadimou, Lasse Folkersen, Martin Berg, et al.
European Urology Focus|March 23, 2022
Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate CancerBram De Laere, Alessio Crippa, Andrea Discacciati, et al.
The Lancet. Oncology|August 15, 2021
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trialTobias Nordström, Andrea Discacciati, Martin Bergman, et al.
Eclinicalmedicine|April 17, 2025
Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort studyAhmad Abbadi, Martin Eklund, Anna Lantz, et al.
European Urology Focus|May 11, 2026
Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate CancerBram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Journal of Thrombosis and Haemostasis : JTH|April 15, 2020
Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: Nationwide cohort studyNina Olausson, Andrea Discacciati, Anastasia I Nyman, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
European Urology Oncology|November 19, 2024
Repeat Prostate Cancer Screening using Blood-based Risk Prediction or Prostate-specific Antigen in the Era of Magnetic Resonance Imaging-guided Biopsies : A Secondary Analysis of the STHLM3-MRI Randomized Clinical TrialAndrea Discacciati, Ahmad Abbadi, Mark S Clements, et al.
Critical Care Medicine|November 16, 2013
B-type natriuretic peptide and risk of acute kidney injury in patients hospitalized with acute coronary syndromes*Marco Moltrasio, Angelo Cabiati, Valentina Milazzo, et al.
The New England Journal of Medicine|July 8, 2021
MRI-Targeted or Standard Biopsy in Prostate Cancer ScreeningMartin Eklund, Fredrik Jäderling, Andrea Discacciati, et al.
JAMA Network Open|February 7, 2024
Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging: A Secondary Analysis of the STHLM3-MRI Randomized Clinical TrialTobias Nordström, Magnus Annerstedt, Axel Glaessgen, et al.
Cardiovascular Research|November 20, 2016
Low TLR7 gene expression in atherosclerotic plaques is associated with major adverse cardio- and cerebrovascular eventsGlykeria Karadimou, Lasse Folkersen, Martin Berg, et al.
European Urology Focus|March 23, 2022
Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate CancerBram De Laere, Alessio Crippa, Andrea Discacciati, et al.
The Lancet. Oncology|August 15, 2021
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trialTobias Nordström, Andrea Discacciati, Martin Bergman, et al.
Eclinicalmedicine|April 17, 2025
Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort studyAhmad Abbadi, Martin Eklund, Anna Lantz, et al.
European Urology Focus|May 11, 2026
Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate CancerBram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Journal of Thrombosis and Haemostasis : JTH|April 15, 2020
Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: Nationwide cohort studyNina Olausson, Andrea Discacciati, Anastasia I Nyman, et al.
Pageof 8